Dengue viruses cluster antigenically but not as discrete serotypes
2015 · Science · 238 citations
https://doi.org/10.1126/science.aac5017
L
Laura A. VanBlargan
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
71
Papers
7.8K
Citations
31
h-index
47
i10-index
Laura A. VanBlargan is an academic researcher from National Institutes of Health. The author has contributed to research in topics: SARS-CoV-2 and COVID-19 Research & COVID-19 Clinical Research Studies & SARS-CoV-2 detection and testing. The author has an h-index of 31, co-authored 61 publications.
ORCID: 0000-0002-8922-8946Papers by this author
worksSystematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cell
2021 · Cell Reports · 149 citations
https://doi.org/10.1016/j.celrep.2021.109364
An mRNA Vaccine Protects Mice against Multiple Tick-Transmitted Flavivirus Infections
2018 · Cell Reports · 124 citations
https://doi.org/10.1016/j.celrep.2018.11.082
A potently neutralizing SARS-CoV-2 antibody inhibits variants of concern by utilizing unique binding residues in a highly conserved epitope
2021 · Immunity · 105 citations
https://doi.org/10.1016/j.immuni.2021.08.016
Distinct sensitivities to SARS-CoV-2 variants in vaccinated humans and mice
2022 · Cell Reports · 16 citations
https://doi.org/10.1016/j.celrep.2022.111299
A broadly reactive antibody targeting the N-terminal domain of SARS-CoV-2 spike confers Fc-mediated protection
2023 · Cell Reports Medicine · 16 citations
https://doi.org/10.1016/j.xcrm.2023.101305
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat